ArQule Inc (NASDAQ:ARQL)

2.10
Delayed Data
As of Mar 27
 -0.08 / -3.67%
Today’s Change
1.04
Today|||52-Week Range
2.50
+72.13%
Year-to-Date
No recent news for ArQule Inc.

Today’s Trading

Previous close2.18
Today’s open2.18
Day’s range2.08 - 2.26
Volume272,445
Average volume (3 months)542,425
Market cap$131.9M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+5.13%
Earnings growth (this year)+12.61%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-29.28%
P/E ratioNM
Price/Sales6.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RNNRexahn Pharmaceutica...+0.01+1.77%
NERVMinerva Neuroscience...-0.07-1.31%
MRNSMarinus Pharmaceutic...-0.25-2.65%
BLPHBellerophon Therapeu...-0.36-3.47%
Data as of 4:00pm ET, 03/27/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$11.3M
Annual profit (last year)-$23.4M
Net profit margin-207.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President, COO, Secretary &
General Counsel
Peter S. Lawrence
Corporate headquarters
Woburn, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account